Navigation Links
Westside Medical Imaging Uses High Resolution Magnetic Imaging to Monitor Effects of Cholesterol Drugs on Atherosclerosis
Date:11/9/2011

BEVERLY HILLS, Calif., Nov. 9, 2011 /PRNewswire/ -- Westside Medical Imaging of Beverly Hills announces the availability of High Resolution Magnetic Resonance Imaging with a 3 Tesla magnet to monitor the effects of cholesterol drugs on atherosclerosis.

Drs.Norman Lepor, Hooman Madyoon and Michael Duffy of Westside Medical Associates of Los Angeles (WMALA) have adopted 3 Tesla magnetic resonance imaging (MRI) using specialized vascular coils to monitor how well cholesterol drugs are working by following carotid plaque volume and morphology. According to Dr. Lepor who has reviewed this issue for the upcoming edition of Reviews in Cardiovascular Medicine, "MRI of plaques with a 3 Tesla magnet represents a pivotal development in vascular medicine. It enhances our capability to identify atherosclerotic plaques with a greater degree of sensitivity then carotid intima-media thickness (cIMT) and follow the effects of medical treatments with more accuracy."

Binh Phan, MD, coauthor of this study found that intensive treatment with cholesterol drugs reduced the amount of cholesterol in artery-clogging plaque in 120 patients who were randomly assigned to receive one of three cholesterol treatments: Lipitor; Lipitor plus Niaspan; or Lipitor plus Niaspan and colesevelam. After three years, the volume of cholesterol decreased from 60.4 cubic mm2 to 37.4 mm2, and the percentage of plaque volume consisting of cholesterol decreased from 14.2% to 7.4%.  

According to Dr. Madyoon, "because atherosclerosis occurs in blood vessels throughout the body, plaque buildup in carotid arteries is a good surrogate marker for build up in the coronary arteries indicating a higher risk of heart attack and stroke." Men over the age of 40 years and women as they approach menopause with a history of hypertension, elevated cholesterol, diabetes, smoking history or family history of heart disease should consider this exam.

These findings confirmed the theory that cholesterol medications lead to plaque regression by lowering cholesterol levels. According to Dr. Lepor, "this MRI technology will also allow physicians to individualize cholesterol therapy rather then treat everyone the same." According to Dr. Duffy, "one of the key advantages of this technology is that you can assess the carotid arteries for plaque progression or regression serially over time since it does not expose the patient to any ionizing radiation."

.


'/>"/>
SOURCE Westside Medical Imaging
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Sky One Medical Announces Third Quarter 2011 Results
2. Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs
3. Cantel Medical Corp. to Present at the Stephens Inc. Fall Investment Conference
4. MAQUET Cardiovascular Completes Acquisition of Atrium Medical Corporation
5. Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems
6. BioMarCare Technologies Ltd. Granted Access to Archived Samples in the Hadassah Medical Center
7. Dehaier Medical to Report Third Quarter 2011 Financial Results on November 14
8. Mindray Medical to Exhibit at MEDICA 2011 in Dusseldorf, Germany from November 16-19, 2011
9. Beating Cardiovascular Disease: Continuing Medical Education Course (CME) in Jackson, MS
10. Newly Launched US BioDesign to Provide OEM Development/Manufacturing Services to Medical Device Customers
11. Rochester Medical Reports Fourth Quarter and Fiscal Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... -- The Bio Supply Management Alliance (BSMA) has announced ... and the Biomedical Manufacturing Network to advance the ... California by providing a platform for imparting ... development. The primary focus of this alliance is to ... as small and mid-sized biomedical companies. ...
(Date:6/10/2017)... 2017  Shane K. Burchfield, DPM, is recognized by Continental Who,s ... Podiatrist in Alabama . Dr. ... Care. He brings over 20 years of experience, as well as ... to his role. ... pleased to welcome you to his practice," the company,s ...
(Date:6/8/2017)... , June 8, 2017  StatLab ... leading developer and manufacturer of diagnostic supplies ... today that Cressey & Company LP ("Cressey ... has completed a growth-focused investment in the ... majority ownership position from selling shareholder, Prairie ...
Breaking Medicine Technology:
(Date:6/20/2017)... ... 20, 2017 , ... United Benefit Advisors (UBA), the nation’s ... (pronounced you-bee) for 2017. The award honors Partner Firms, Principals, agency staff, ... the clients they serve, and the benefits insurance industry as a whole. , ...
(Date:6/20/2017)... ... June 20, 2017 , ... Caduceus International Publishing ... to announce a new online course entitled Personal & Community Health ... evidence-based strategies for achieving optimal well-being and teaches students how to apply them ...
(Date:6/20/2017)... , ... June 20, 2017 , ... Fresenius Vascular Care, ... minimally invasive techniques to treat and manage a wide range of vascular conditions, has ... initiative. With more than 65 centers represented by more than 40 local brands, a ...
(Date:6/20/2017)... ... 20, 2017 , ... EdChoice and the American Enterprise Institute ... promote economic development in economically distressed urban areas. The first report presents a ... to the economic development of the city of Santa Ana, California. The second ...
(Date:6/20/2017)... New York, NY (PRWEB) , ... June 20, 2017 , ... ... announced today their continued expansion and success in the clinical trials market. Similar to ... building a track record in the clinical trials marketplace by proving the value of ...
Breaking Medicine News(10 mins):